Last updated on April 2020

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of Canagliflozin (TA-7284) in Japanese patients with Diabetic Nephropathy, compared with placebo

Clinical Study Identifier: NCT03436693

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.